By Kurt Orzeck ( April 14, 2016, 1:13 AM EDT) -- Walgreens, CVS and other retail pharmacy chains on Wednesday urged the Third Circuit not to decertify a purchaser class accusing Mylan and Ranbaxy Laboratories of improperly inking pay-for-delay deals with Cephalon to keep generic versions of narcolepsy drug Provigil off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.